• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    LifeMDᵀᴹ Appoints Prominent Dermatologist Dr. Matthew Zipoli as a Lead Medical Advisor for Tele-dermatology Brand Nava MDᵀᴹ

    5/24/21 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care
    Get the next $LFMD alert in real time by email

    NEW YORK, May 24, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. ("the Company") (NASDAQ:LFMD), a leading direct-to-patient telehealth company, today announced the appointment of prominent dermatologist and surgeon, Dr. Matthew Zipoli, as a medical advisor for tele-dermatology brand Nava MD. Dr. Zipoli will collaborate with the Company to further enhance the brand's development goals.

    With over two decades of experience, Dr. Zipoli is a leading specialist in Mohs Surgery for the treatment of skin cancers. He is affiliated with Mount Auburn and Emerson Hospitals in the greater-Boston area, and serves as a Clinical Instructor at Tufts University School of Medicine. Dr. Zipoli graduated from Boston University School of Medicine and completed his surgical fellowship at the University of California San Francisco Medical Center. Boston Magazine named Dr. Zipoli to its annual "Best of Boston: Top Doctors" list for the past 6 years running.

    Dr. Anthony Puopolo, LifeMD's Chief Medical Officer, commented on the appointment: "We welcome the addition of Dr. Zipoli, a leading dermatologist and surgeon. His guidance will support Nava MD's mission to become the leading, virtual point-of-care tele-dermatology brand in the market. As we continue to optimize the Nava MD platform, we are confident in our ability to drive both increasing subscriber base and brand recognition for our tele-dermatology products and patient services."

    About Nava MD

    Nava MD is LifeMD's tele-dermatology and clinical skincare brand for women that offers virtual medical treatment from dermatologists and other medical providers in all 50 states. Following a custom consultation, a personalized treatment plan is prescribed based on a patient's skincare needs. Nava MD's proprietary products leverage intellectual property and proprietary formulations licensed from Restorsea, a leading skincare technology platform. Treatment plans, if appropriate, may also include prescription oral and compounded topical medications to treat many common dermatological conditions. To learn more, visit https://navamd.com

    About LifeMD

    LifeMD, Inc. is a rapidly growing direct-to-patient, telehealth company, offering cash-pay virtual medical care across all 50 states. LifeMD's telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient's home. To learn more, visit https://www.lifemd.com

    Cautionary Note Regarding Forward Looking Statements

    This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things our plans, strategies and prospects -- both business and financial. While we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to LifeMD, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.

    Company Contact

    LifeMD, Inc.

    Marc Benathen, CFO

    Email Contact

    Investor Relations Contact

    Ashley Robinson

    LifeSci Advisors, LLC

    [email protected]



    Primary Logo

    Get the next $LFMD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LFMD

    DatePrice TargetRatingAnalyst
    6/18/2025$15.00 → $18.00Buy
    BTIG Research
    12/10/2024$12.00Buy
    Lake Street
    12/4/2024$7.00Neutral
    Mizuho
    8/23/2024$11.00Buy
    B. Riley Securities
    6/5/2024$12.00Overweight
    KeyBanc Capital Markets
    11/30/2023$10.00Buy
    Craig Hallum
    7/21/2023$7.00Overweight
    Cantor Fitzgerald
    7/3/2023$9.00Buy
    H.C. Wainwright
    More analyst ratings

    $LFMD
    SEC Filings

    View All

    SEC Form 10-Q filed by LifeMD Inc.

    10-Q - LifeMD, Inc. (0000948320) (Filer)

    8/5/25 4:46:27 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - LifeMD, Inc. (0000948320) (Filer)

    8/5/25 4:10:43 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    LifeMD Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - LifeMD, Inc. (0000948320) (Filer)

    7/31/25 4:36:09 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    $LFMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Schreiber Justin sold $249,690 worth of shares (25,000 units at $9.99) (SEC Form 4)

    4 - LifeMD, Inc. (0000948320) (Issuer)

    8/5/25 5:14:36 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    Chief Operating Officer Dray Shayna Webb was granted 50,000 shares, increasing direct ownership by 23% to 265,000 units (SEC Form 4)

    4 - LifeMD, Inc. (0000948320) (Issuer)

    7/31/25 4:43:24 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    New insider Dray Shayna Webb claimed ownership of 215,000 shares (SEC Form 3)

    3 - LifeMD, Inc. (0000948320) (Issuer)

    7/31/25 4:41:58 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    $LFMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Innovation Officer Galluppi Stefan bought $14,790 worth of shares (3,000 units at $4.93), increasing direct ownership by 7% to 45,449 units (SEC Form 4)

    4 - LifeMD, Inc. (0000948320) (Issuer)

    9/12/24 2:10:03 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    $LFMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medifast Announces Second Quarter 2025 Financial Results

    Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2025. Second Quarter 2025 Revenue: $105.6 million, with revenue per active earning coach of $4,630 Active Coaches: Independent active earning OPTAVIA coaches of 22,800 Net Income: $2.5 million or $0.22 per diluted share, which includes a gain on investment in LifeMD (NASDAQ:LFMD) common stock of $2.0 million (net of tax) Strong Balance Sheet: $162.7 million in cash, cash equivalents, and investment securities with no debt "We are working diligently to transform our business as we look to he

    8/4/25 4:05:00 PM ET
    $LFMD
    $MED
    Medical/Nursing Services
    Health Care
    Packaged Foods
    Consumer Staples

    LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference

    NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced its participation in the Canaccord Genuity 45th Annual Growth Conference, which will be held August 12-14, 2025 at the InterContinental Boston. Management will participate in a fireside chat on Wednesday, August 13th at 8:30 a.m. Eastern time and will hold one-on-one meetings with investors on August 12-13. Investors can register for the conference by contacting their Canaccord Genuity representative. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and

    8/4/25 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    LifeMD Names COO and Promotes Two Executives

    NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating Officer. Ms. Webb Dray, an accomplished operations and supply chain executive with over 15 years of experience, has been an integral part of LifeMD's growth, most recently serving as Senior Vice President of Operations. "Shayna's proven track record of building and managing an industry-leading operations team and infrastructure in a complex and rapidly growing environment makes her the ideal leader to step into the role of COO," said Justin Schreiber, Chairman and Chief Executive Officer of L

    7/31/25 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    $LFMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research reiterated coverage on LifeMD with a new price target

    BTIG Research reiterated coverage of LifeMD with a rating of Buy and set a new price target of $18.00 from $15.00 previously

    6/18/25 10:55:14 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    Lake Street initiated coverage on LifeMD with a new price target

    Lake Street initiated coverage of LifeMD with a rating of Buy and set a new price target of $12.00

    12/10/24 8:29:49 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    Mizuho initiated coverage on LifeMD with a new price target

    Mizuho initiated coverage of LifeMD with a rating of Neutral and set a new price target of $7.00

    12/4/24 7:42:36 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    $LFMD
    Financials

    Live finance-specific insights

    View All

    Medifast Announces Second Quarter 2025 Financial Results

    Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2025. Second Quarter 2025 Revenue: $105.6 million, with revenue per active earning coach of $4,630 Active Coaches: Independent active earning OPTAVIA coaches of 22,800 Net Income: $2.5 million or $0.22 per diluted share, which includes a gain on investment in LifeMD (NASDAQ:LFMD) common stock of $2.0 million (net of tax) Strong Balance Sheet: $162.7 million in cash, cash equivalents, and investment securities with no debt "We are working diligently to transform our business as we look to he

    8/4/25 4:05:00 PM ET
    $LFMD
    $MED
    Medical/Nursing Services
    Health Care
    Packaged Foods
    Consumer Staples

    LifeMD to Report Second Quarter 2025 Financial Results on August 5

    NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on August 5, 2025, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Tuesday, August 5thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-445-7795International Dial-In:785-424-1699Conference ID:LIFEMDLive & Archived Webcast:Link About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pha

    7/29/25 4:05:00 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025

    Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended June 30, 2025 on Monday, August 4, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 4, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https:

    7/21/25 4:05:00 PM ET
    $LFMD
    $MED
    Medical/Nursing Services
    Health Care
    Packaged Foods
    Consumer Staples

    $LFMD
    Leadership Updates

    Live Leadership Updates

    View All

    LifeMD Names COO and Promotes Two Executives

    NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating Officer. Ms. Webb Dray, an accomplished operations and supply chain executive with over 15 years of experience, has been an integral part of LifeMD's growth, most recently serving as Senior Vice President of Operations. "Shayna's proven track record of building and managing an industry-leading operations team and infrastructure in a complex and rapidly growing environment makes her the ideal leader to step into the role of COO," said Justin Schreiber, Chairman and Chief Executive Officer of L

    7/31/25 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    LifeMD Set to Join the Russell 3000 Index

    NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective at the open of U.S. equity markets on Monday, July 1st, according to a preliminary list of additions posted Friday, May 24th. The annual Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks as of Tuesday, April 30th, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Ind

    5/29/24 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    LifeMD Appoints Dr. Calum MacRae to its Board of Directors

    NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors. "We are delighted to welcome Dr. MacRae to the LifeMD Board of Directors. He brings deep experience in cardiology, internal medicine and clinical innovation, with a focus on disease management and the implementation of novel solutions to improve the delivery of virtual healthcare services," said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. "Aside from being a world-reno

    4/29/24 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    $LFMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LifeMD Inc.

    SC 13G/A - LifeMD, Inc. (0000948320) (Subject)

    11/14/24 10:42:44 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by LifeMD Inc. (Amendment)

    SC 13G/A - LifeMD, Inc. (0000948320) (Subject)

    2/14/24 3:33:22 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by LifeMD Inc.

    SC 13G - LifeMD, Inc. (0000948320) (Subject)

    10/6/23 5:26:16 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care